Key facts
- Zhuorun Biotechnology’s last known valuation is $51.4M (Oct 2023).
- Notable investors include Shenzhen Capital Group, Yhlo.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Zhuorun Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Zhuorun Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Zhuorun Biotechnology
Manufacturer of in vitro diagnostic products intended for the biopharmaceutical industry. The company's range of products includes single-use chemiluminescence immunoassay analysers, immunodiagnostic reagents, fluorescence immunochromatography kits, chemiluminescence detection systems, and microfluidic diagnostic platforms, thereby supporting accurate, rapid and scalable diagnostic testing.
- Sector
- Healthcare
- HQ
- Shenzhen, China
- Founded
- 2019
- Employees
- 180
- Website
- szdrawray.com/
- Ownership
- Privately Held (backing)
Zhuorun Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Zhuorun Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Zhuorun Biotechnology in its N-PORT filings yet. We sweep new filings monthly.